Skip to content

The effects of eight weeks aerobic, resistance, and combined exercises on plasma Irisin levels, insulin resistance and lipid profiles among obese women with metabolic syndrome

The effects of eight weeks aerobic, resistance, and combined exercises on plasma Irisin levels, insulin resistance and lipid profiles among obese women with metabolic syndrome

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180806040721N2
Enrollment
60
Registered
2018-10-20
Start date
2016-12-01
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Metabolic syndrome. Condition 2: Diabets. Metabolic syndrome Diabetes mellitus due to underlying condition

Interventions

Intervention 1: Intervention group first: Aerobic training group En. Participants of this group performed their activities using treadmill or bicycle th

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
45 Years to 60 Years

Inclusion criteria

Inclusion criteria: Having at least 3 components of metabolic syndrome Women 45-60 years old No history of any specific disease (cancer, diabetes, cardiovascular problems, Skeletal-muscular problems)

Exclusion criteria

Exclusion criteria: diagnosed with history of any specific disease (cancer, diabetes, cardiovascular problems, Skeletal-muscular problems)

Design outcomes

Primary

MeasureTime frame
Irisin. Timepoint: measurement at the beginning of the study (before the intervention) and 2 months after the intervention. Method of measurement: Measurement Plasma Irisin Level Using Elis Kit Made in Germany.

Secondary

MeasureTime frame
Glocose. Timepoint: At the beginning of the study (before the intervention) and two months after the intervention began. Method of measurement: fasting blood glucose (glucose oxidase) measured.;Insulin. Timepoint: At the beginning of the study (before the intervention) and two months after the intervention began. Method of measurement: The level of insulin was measured by ELISA.;Triglyceride. Timepoint: At the beginning of the study (before the intervention) and two months after the intervention began. Method of measurement: triglyceride (PAP-GPO / lipase) measured.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDianatinasab Mostafa

Shiraz University of Medical Sciences

dianatinasab@sums.ac.ir+98 71 5383 4701

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 27, 2026